Donepezil: Difference between revisions
David Canner (talk | contribs) No edit summary |
David Canner (talk | contribs) No edit summary |
||
Line 46: | Line 46: | ||
! [[Pharmaceutical_Drugs#Protein_Binding|Protein Binding]] (%) | ! [[Pharmaceutical_Drugs#Protein_Binding|Protein Binding]] (%) | ||
! 96 | ! 96 | ||
! | ! 55 | ||
! | ! 40 | ||
! | ! 10 | ||
! | ! 20 | ||
|- | |- | ||
! [[Pharmaceutical_Drugs#Half_Life_.28T1.2F2.29|T<sub>1/2</sub>]] (hr) | ! [[Pharmaceutical_Drugs#Half_Life_.28T1.2F2.29|T<sub>1/2</sub>]] (hr) | ||
! 70 | ! 70 | ||
! | ! 2-4 | ||
! | ! 5 | ||
! | ! 4.4-5.7 | ||
! | ! 2 | ||
|- | |- | ||
! [[Pharmaceutical_Drugs#Area_Under_the_Curve_.28AUC.29|AUC]] (ng/ml/hr) | ! [[Pharmaceutical_Drugs#Area_Under_the_Curve_.28AUC.29|AUC]] (ng/ml/hr) | ||
Line 73: | Line 73: | ||
! Dosage (mg) | ! Dosage (mg) | ||
! 5 | ! 5 | ||
! | ! 160 | ||
! [[Rivastigmine]] | ! [[Rivastigmine]] | ||
! | ! 20-50 | ||
! | ! 30 | ||
|- | |- | ||
! Metabolism | ! Metabolism |